You are Trying to View a Free ArticleDaily News You Can't Find Anywhere Else
Catalent Continues to Make Investments, an Industrial Info Market Brief
Industry Segment: Pharmaceutical & Biotech | Word Count: 66 Words
Industrial Info is tracking eight operational plants across Europe (see map below) owned by Catalent Pharma Solutions, a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. Globally, Industrial Info is tracking more than $300 million worth of project activity by Catalent.
Catalent recently announced plans to invest $27 million to commercialize ZydisŪ Ultra, an oral disintegrating tablet.
Subscribe Now! All Fields Required...
- Pharma-Bio Industry Grassroot Plant Investment at $68 Billion, an Industria...
- Seattle Evolves As Biotech Hub, an Industrial Info Market Brief
- API Production in India to Improve by 2020, an Industrial Info Market Brief
- Cosmetics Sector Booms in Europe, an Industrial Info Market Brief
- Europe Launches High-Tech System to Detect Fake Medicines
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker